HEALTHCARE REALTY TRUST INCORPORATED (HR) capitalization

Current snapshot

Market Cap
$5.89B
346.5M shares × $16.99 · as of last filing 2026-03-31
Net Worth
$4.44B
Stockholders' equity · 2026-03-31
Enterprise Value
$10.20B
Market cap + debt − cash
Net Debt
$4.31B
Debt $4.34B − Cash $26.2M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $5.93B
FY'24 2024-12-31 $6.20B
FY'23 2023-12-31 $6.53B
FY'22 2022-12-31 $4.89B
FY'21 2021-12-31 $4.52B
FY'20 2020-12-31 $3.97B
FY'19 2019-12-31 $6.99B
FY'18 2018-12-31 $5.97B
FY'17 2017-12-31 $5.95B
FY'16 2016-12-31 $4.25B
FY'15 2015-12-31 $3.63B
FY'14 2014-12-31 $3.31B
FY'13 2013-12-31 $1.23B
FY'12 2012-12-31 $1.34B
FY'11 2011-12-31 $2.09B
FY'11 2010-12-31 $1.76B
FY'11 2009-12-31 $1.21B

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $5.90B
Q4'25 2025-12-31 $5.96B
Q3'25 2025-09-30 $6.31B
Q2'25 2025-06-30 $5.55B
Q1'25 2025-03-31 $5.91B
Q4'24 2024-12-31 $5.94B
Q3'24 2024-09-30 $6.52B
Q2'24 2024-06-30 $6.14B
Q1'24 2024-03-31 $5.37B
Q4'23 2023-12-31 $6.56B
Q3'23 2023-09-30 $5.79B
Q2'23 2023-06-30 $7.15B
Q1'23 2023-03-31 $7.32B
Q4'22 2022-12-31 $7.33B
Q3'22 2022-09-30 $6.92B
Q3'22 2022-07-20 $5.56B
Q2'22 2022-06-30 $4.07B
Q1'22 2022-03-31 $4.10B
Q4'21 2021-12-31 $4.76B
Q3'21 2021-09-30 $4.28B
Q2'21 2021-06-30 $4.29B
Q1'21 2021-03-31 $6.74B
Q4'20 2020-12-31 $6.47B
Q3'20 2020-09-30 $6.58B
Q2'20 2020-06-30 $6.50B
Q1'20 2020-03-31 $6.16B
Q4'19 2019-12-31 $7.22B
Q3'19 2019-09-30 $6.88B
Q2'19 2019-06-30 $6.55B
Q1'19 2019-03-31 $6.71B
Q4'18 2018-12-31 $5.84B
Q3'18 2018-09-30 $6.19B
Q2'18 2018-06-30 $6.09B
Q1'18 2018-03-31 $5.80B
Q4'17 2017-12-31 $6.58B
Q3'17 2017-09-30 $6.62B
Q2'17 2017-06-30 $6.03B
Q1'17 2017-03-31 $4.75B
Q4'16 2016-12-31 $4.30B
Q3'16 2016-09-30 $4.88B
Q2'16 2016-06-30 $4.92B
Q1'16 2016-03-31 $4.05B
Q4'15 2015-12-31 $3.70B
Q3'15 2015-09-30 $3.20B
Q2'15 2015-06-30 $2.96B
Q1'15 2015-03-31 $3.53B
Q4'14 2014-12-31 $3.42B
Q3'14 2014-09-30 $1.43B
Q2'14 2014-06-30 $1.53B
Q1'14 2014-03-31 $1.45B
Q4'13 2013-12-31 $2.53B
Q3'13 2013-09-30 $2.72B
Q2'13 2013-06-30 $2.90B
Q1'13 2013-03-31 $3.11B
Q4'12 2012-12-31 $2.57B
Q3'12 2012-09-30 $2.52B
Q2'12 2012-06-30 $2.73B
Q1'12 2012-03-31 $2.52B
Q4'11 2011-12-31 $2.12B
Q3'11 2011-09-30 $1.93B
Q2'11 2011-06-30 $2.36B
Q1'12 2011-03-31 $2.44B
Q4'11 2010-12-31 $2.14B
Q3'11 2010-09-30 $1.95B
Q2'11 2010-06-30 $1.70B

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (HR CIK 0001360604), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

PLX

PROTALIX BIOTHERAPEUTICS, INC.

ALOT

AstroNova, Inc.

GALT

GALECTIN THERAPEUTICS INC.